Advertisement
Singapore markets closed
  • Straits Times Index

    3,275.69
    -12.06 (-0.37%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,108.40
    +29.54 (+0.37%)
     
  • Bitcoin USD

    64,389.74
    +380.66 (+0.59%)
     
  • CMC Crypto 200

    1,388.57
    -7.96 (-0.57%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,359.30
    +16.80 (+0.72%)
     
  • Crude Oil

    83.66
    +0.09 (+0.11%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,060.97
    -94.32 (-1.32%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Which Growth Stock Is a Better Buy Right Now -- AbbVie or InMode?

The popularity of cosmetic procedures is unquestionably on the rise. Major pharmaceutical AbbVie (NYSE: ABBV) is plagued by concerns about the impending patent cliff on its top-selling drug. At the same time, healthcare equipment provider InMode (NASDAQ: INMD) has been punished by Wall Street's current skepticism about growth stocks.